Chemoinformaics analysis of Methyl palmitoleate
| Molecular Weight | 268.441 | nRot | 13 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 2 |
| Exact Molecular Weight | 268.24 | nRing | 0 |
| Solubility: LogS | -4.187 | nHRing | 0 |
| Solubility: LogP | 5.68 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 51.3314 |
| nHD | 0 | BPOL | 34.7066 |
| QED | 0.253 |
| Synth | 2.044 |
| Natural Product Likeliness | 0.804 |
| NR-PPAR-gamma | 0.136 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.001 |
| HIA | 0.018 |
| CACO-2 | -4.771 |
| MDCK | 0.0000278 |
| BBB | 0.869 |
| PPB | 0.973662 |
| VDSS | 2.319 |
| FU | 0.0189311 |
| CYP1A2-inh | 0.753 |
| CYP1A2-sub | 0.445 |
| CYP2c19-inh | 0.508 |
| CYP2c19-sub | 0.189 |
| CYP2c9-inh | 0.375 |
| CYP2c9-sub | 0.938 |
| CYP2d6-inh | 0.33 |
| CYP2d6-sub | 0.403 |
| CYP3a4-inh | 0.65 |
| CYP3a4-sub | 0.105 |
| CL | 5.202 |
| T12 | 0.841 |
| hERG | 0.243 |
| Ames | 0.022 |
| ROA | 0.042 |
| SkinSen | 0.956 |
| Carcinogencity | 0.123 |
| EI | 0.885 |
| Respiratory | 0.86 |
| NR-Aromatase | 0.047 |
| Antiviral | Yes |
| Prediction | 0.642868 |